Logo image of ERF.PA

EUROFINS SCIENTIFIC (ERF.PA) Stock Fundamental Analysis

EPA:ERF - Euronext Paris - Matif - FR0014000MR3 - Common Stock - Currency: EUR

60.6  -0.02 (-0.03%)

Fundamental Rating

6

Taking everything into account, ERF scores 6 out of 10 in our fundamental rating. ERF was compared to 19 industry peers in the Life Sciences Tools & Services industry. ERF scores excellent on profitability, but there are some minor concerns on its financial health. ERF is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ERF was profitable.
In the past year ERF had a positive cash flow from operations.
ERF had positive earnings in each of the past 5 years.
In the past 5 years ERF always reported a positive cash flow from operatings.
ERF.PA Yearly Net Income VS EBIT VS OCF VS FCFERF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

ERF has a better Return On Assets (3.24%) than 73.68% of its industry peers.
ERF's Return On Equity of 6.61% is fine compared to the rest of the industry. ERF outperforms 73.68% of its industry peers.
ERF has a Return On Invested Capital of 9.18%. This is in the better half of the industry: ERF outperforms 73.68% of its industry peers.
ERF had an Average Return On Invested Capital over the past 3 years of 8.70%. This is in line with the industry average of 7.38%.
The last Return On Invested Capital (9.18%) for ERF is above the 3 year average (8.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.24%
ROE 6.61%
ROIC 9.18%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ERF.PA Yearly ROA, ROE, ROICERF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ERF's Profit Margin of 5.08% is in line compared to the rest of the industry. ERF outperforms 57.89% of its industry peers.
ERF's Profit Margin has improved in the last couple of years.
ERF has a Operating Margin of 14.97%. This is in the better half of the industry: ERF outperforms 63.16% of its industry peers.
In the last couple of years the Operating Margin of ERF has grown nicely.
ERF has a worse Gross Margin (22.33%) than 78.95% of its industry peers.
In the last couple of years the Gross Margin of ERF has grown nicely.
Industry RankSector Rank
OM 14.97%
PM (TTM) 5.08%
GM 22.33%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
ERF.PA Yearly Profit, Operating, Gross MarginsERF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

ERF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ERF has less shares outstanding
The number of shares outstanding for ERF has been increased compared to 5 years ago.
The debt/assets ratio for ERF has been reduced compared to a year ago.
ERF.PA Yearly Shares OutstandingERF.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ERF.PA Yearly Total Debt VS Total AssetsERF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

ERF has an Altman-Z score of 2.74. This is not the best score and indicates that ERF is in the grey zone with still only limited risk for bankruptcy at the moment.
ERF has a Altman-Z score (2.74) which is comparable to the rest of the industry.
The Debt to FCF ratio of ERF is 4.57, which is a neutral value as it means it would take ERF, 4.57 years of fcf income to pay off all of its debts.
ERF has a better Debt to FCF ratio (4.57) than 63.16% of its industry peers.
ERF has a Debt/Equity ratio of 0.59. This is a neutral value indicating ERF is somewhat dependend on debt financing.
ERF has a Debt to Equity ratio (0.59) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.57
Altman-Z 2.74
ROIC/WACC1.19
WACC7.72%
ERF.PA Yearly LT Debt VS Equity VS FCFERF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.16 indicates that ERF should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, ERF is doing worse than 78.95% of the companies in the same industry.
A Quick Ratio of 1.09 indicates that ERF should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.09, ERF is in line with its industry, outperforming 47.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.09
ERF.PA Yearly Current Assets VS Current LiabilitesERF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.63% over the past year.
The Earnings Per Share has been growing by 18.34% on average over the past years. This is quite good.
ERF shows a small growth in Revenue. In the last year, the Revenue has grown by 6.70%.
The Revenue has been growing by 8.78% on average over the past years. This is quite good.
EPS 1Y (TTM)40.63%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%13.46%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%6.87%

3.2 Future

ERF is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.47% yearly.
Based on estimates for the next years, ERF will show a small growth in Revenue. The Revenue will grow by 6.47% on average per year.
EPS Next Y15.29%
EPS Next 2Y14.58%
EPS Next 3Y14%
EPS Next 5Y13.47%
Revenue Next Year6.31%
Revenue Next 2Y6.36%
Revenue Next 3Y6.54%
Revenue Next 5Y6.47%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ERF.PA Yearly Revenue VS EstimatesERF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ERF.PA Yearly EPS VS EstimatesERF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

ERF is valuated quite expensively with a Price/Earnings ratio of 33.67.
ERF's Price/Earnings is on the same level as the industry average.
ERF is valuated rather expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
ERF is valuated rather expensively with a Price/Forward Earnings ratio of 17.02.
84.21% of the companies in the same industry are more expensive than ERF, based on the Price/Forward Earnings ratio.
ERF is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.67
Fwd PE 17.02
ERF.PA Price Earnings VS Forward Price EarningsERF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ERF's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ERF is cheaper than 89.47% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ERF indicates a rather cheap valuation: ERF is cheaper than 94.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.96
EV/EBITDA 8.1
ERF.PA Per share dataERF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ERF has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ERF's earnings are expected to grow with 14.00% in the coming years.
PEG (NY)2.2
PEG (5Y)1.84
EPS Next 2Y14.58%
EPS Next 3Y14%

4

5. Dividend

5.1 Amount

ERF has a yearly dividend return of 0.99%, which is pretty low.
ERF's Dividend Yield is rather good when compared to the industry average which is at 0.72. ERF pays more dividend than 89.47% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, ERF's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.99%

5.2 History

On average, the dividend of ERF grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ERF.PA Yearly Dividends per shareERF.PA Yearly Dividends per shareYearly Dividends per share 2018 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

27.77% of the earnings are spent on dividend by ERF. This is a low number and sustainable payout ratio.
ERF's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP27.77%
EPS Next 2Y14.58%
EPS Next 3Y14%
ERF.PA Yearly Income VS Free CF VS DividendERF.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ERF.PA Dividend Payout.ERF.PA Dividend Payout, showing the Payout Ratio.ERF.PA Dividend Payout.PayoutRetained Earnings

EUROFINS SCIENTIFIC

EPA:ERF (7/11/2025, 7:00:00 PM)

60.6

-0.02 (-0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)04-23 2025-04-23
Earnings (Next)07-23 2025-07-23
Inst Owners34.16%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.04B
Analysts68.89
Price Target60.33 (-0.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.99%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP27.77%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.61%
PT rev (3m)1.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.16%
Valuation
Industry RankSector Rank
PE 33.67
Fwd PE 17.02
P/S 1.59
P/FCF 13.96
P/OCF 8.37
P/B 2.07
P/tB N/A
EV/EBITDA 8.1
EPS(TTM)1.8
EY2.97%
EPS(NY)3.56
Fwd EY5.88%
FCF(TTM)4.34
FCFY7.16%
OCF(TTM)7.24
OCFY11.95%
SpS38.16
BVpS29.31
TBVpS-1.59
PEG (NY)2.2
PEG (5Y)1.84
Profitability
Industry RankSector Rank
ROA 3.24%
ROE 6.61%
ROCE 11.86%
ROIC 9.18%
ROICexc 9.87%
ROICexgc 31.79%
OM 14.97%
PM (TTM) 5.08%
GM 22.33%
FCFM 11.37%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexcg growth 3Y-18.17%
ROICexcg growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score8
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.57
Debt/EBITDA 1.81
Cap/Depr 76.4%
Cap/Sales 7.6%
Interest Coverage 9.11
Cash Conversion 76.13%
Profit Quality 224%
Current Ratio 1.16
Quick Ratio 1.09
Altman-Z 2.74
F-Score8
WACC7.72%
ROIC/WACC1.19
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)40.63%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%13.46%
EPS Next Y15.29%
EPS Next 2Y14.58%
EPS Next 3Y14%
EPS Next 5Y13.47%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%6.87%
Revenue Next Year6.31%
Revenue Next 2Y6.36%
Revenue Next 3Y6.54%
Revenue Next 5Y6.47%
EBIT growth 1Y23.67%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year87.7%
EBIT Next 3Y30.85%
EBIT Next 5Y22.29%
FCF growth 1Y68.95%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y29.56%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%